Effect of CYP2C19 Genotype on Inhibition of Platelet Aggregation in Hemodialysis Patients With Coronary Artery Disease

被引：0
|
作者：
Waseda, Katsuhisa
Saka, Yuki
Takashima, Hiroaki
Kurita, Akiyoshi
Ando, Hirohiko
Sakurai, Shinichiro
Suzuki, Akihiro
Sawada, Hiroaki
Sato, Shigeko
Nishikawa, Yoshinori
Amano, Tetsuya
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Antiplatelet drugs; Prasugrel; Clopidogrel; Renal function; Genetics;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14237
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Rapid CYP2C19 Genotype Testing: Comparison between Spartan RX CYP2C19 and Verigene CYP2C19
    Zhou, Y.
    Armstead, A. R.
    Coshatt, G. M.
    Brott, B. C.
    Sankaranarayanan, A.
    Limdi, N. A.
    Harada, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [22] Impact of CYP2C19 polymorphism and smoking on response to clopidogrel in patients with stable coronary artery disease
    Liu Xiao-li
    Wang Zhi-jian
    Yang Qing
    Ge Hai-long
    Gao Fei
    Liu Yu-yang
    Shi Dong-mei
    Zhao Ying-xin
    Zhou Yu-jie
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3178 - 3183
  • [23] Impact of CYP2C19 polymorphism and smoking on response to clopidogrel in patients with stable coronary artery disease
    中华医学杂志(英文版), 2010, (22) : 3178 - 3183
  • [24] The effect of CYP2C19 genotype on the platelet responsiveness to clopidogrel in healthy Korean subjects.
    Cho, D.
    Yeo, C.
    Oh, M.
    Shon, J.
    Kim, E.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S69 - S69
  • [25] Impact of CYP2C19 polymorphism and smoking on response to clopidogrel in patients with stable coronary artery disease
    LIU XiaoliWANG ZhijianYANG QingGE HailongGAO FeiLIU YuyangSHI Dongmei ZHAO Yingxin and ZHOU Yujie Department of CardiologyBeijing Anzhen HospitalCapital Medical UniversityBeijing China
    CHINESEMEDICALJOURNAL, 2010, (22)
  • [26] The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients
    Amin, Arwa M.
    Chin, Lim Sheau
    Noor, Dzul Azri Mohamed
    Mostafa, Hamza
    Kader, Muhamad Ali S. K. Abdul
    Hay, Yuen Kah
    Ibrahim, Baharudin
    THROMBOSIS RESEARCH, 2017, 158 : 22 - 24
  • [27] A Study On The Impact Of CYP2C19 Genotype And Platelet Reactivity Assay On Patients Undergoing PCI
    Chidambaram, Sundar
    Rath, Prathap C.
    Dixit, Byomakesh
    Rath, Pallavi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B87 - B87
  • [28] Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms
    Chen, Bi-Lian
    Zhang, Wei
    Li, Qing
    Li, Ya-Lin
    He, Yi-Jing
    Fan, Lan
    Wang, Lian-Sheng
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (08) : 904 - 908
  • [29] Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
    Klomp, Sylvia D.
    Veringa, Anette
    Alffenaar, Jan-Willem C.
    de Boer, Mark G. J.
    Span, Lambert F. R.
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (07):
  • [30] Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease
    Hokimoto, Seiji
    Tabata, Noriaki
    Akasaka, Tomonori
    Arima, Yuichiro
    Kaikita, Koichi
    Morita, Kazunori
    Kumagae, Naoki
    Oniki, Kentaro
    Nakagawa, Kazuko
    Ogawa, Hisao
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (02) : 148 - 152
12345